Results 201 to 210 of about 861,864 (406)

A novel approach: a pancreatic duct stent removable with the nasobiliary catheter. [PDF]

Endoscopy
Long H, Wang P, Yang W, Ren Y, Yang B, Wen S, Guo M.   +6 more
europepmc   +1 more source

Distal Pancreatic Duct Inflammation

Annals of Surgery, 1970
J M, Acosta, G L, Nardi, F, Civantos
openaire   +3 more sources

256P PIK3CA mutations in pancreatic ductal adenocarcinoma (PDAC) [PDF]

O. Pitiyarachchi, H-W. Sim
openalex   +1 more source

Figure S4 from Mucin Expression and Splicing Determine Novel Subtypes and Patient Mortality in Pancreatic Ductal Adenocarcinoma

, 2023
Christopher M. Thompson, Andrew Cannon, Sean West, Dario Ghersi, Pranita Atri, Rakesh Bhatia, Lynette M. Smith, Satyayanarayana Rachagani, Christopher Wichman, Sushil Kumar, Surinder K. Batra   +10 more
openalex   +1 more source

Pancreatic duct cells as a source of VEGF in mice

Diabetologia, 2014
Xiangwei Xiao, K. Prasadan, Ping Guo, Y. El-Gohary, Shane Fischbach, J. Wiersch, I. Gaffar, C. Shiota, G. Gittes   +8 more
semanticscholar   +1 more source

Functional Advantage of Central Pancreatectomy Over Distal Pancreatectomy for Benign or Low‐Grade Malignant Tumors: A Comparative Analysis Based on 75‐g Oral Glucose Tolerance Test

Annals of Gastroenterological Surgery, EarlyView.
Central pancreatectomy (CP) better preserves postoperative pancreatic endocrine function than distal pancreatectomy for benign or low‐grade malignant tumors. The 75‐g oral glucose tolerance test demonstrated that CP maintained insulin secretion and glucose tolerance, highlighting its clinical advantage as a function‐preserving procedure.
Dongha Lee, Keiko Kamei, Chihoko Nobori, Yuta Yoshida, Takaaki Murase, Atsushi Takebe, Yuki Okuda, Naru Babaya, Yoshihisa Hiromine, Ippei Matsumoto   +9 more
wiley   +1 more source

Mechanism and treatment of pancreatic duct stones. [PDF]

World J Gastrointest Surg
Wu S, Zheng Y, Mou JW, Zhang YJ, Zhu KX.
europepmc   +1 more source

Experience with 13 segmental pancreas transplants in cyclosporine treated diabetic patients using ethibloc for duct obliteration: surgical aspects [PDF]

, 1984
Abendroth, D., Illner, Wolf-Dieter, Land, Walter, Landgraf, R.   +3 more
core   +1 more source

To Evaluate Whether Pretreatment CA19‐9 and DUPAN‐2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Cancer

Annals of Gastroenterological Surgery, EarlyView.
NAT‐GS was significantly more effective only in patients with one tumor marker above the reference range, comparing those who achieved 12‐month MRFS with those who did not. ABSTRACT Aim Pancreatic cancer (PC) remains one of the most lethal malignancies, with early recurrence severely affecting prognosis even after curative resection.
Hiromichi Kawaida, Wataru Izumo, Ryo Saito, Hidetake Amemiya, Suguru Maruyama, Katsutoshi Shoda, Kensuke Shiraishi, Shinji Furuya, Yoshihiko Kawaguchi, Daisuke Ichikawa   +9 more
wiley   +1 more source

Novel biopsy forceps removed pancreatic duct foreign bodies in disconnected pancreatic duct syndrome via endoscopic ultrasound-guided pancreatic duct drainage fistula. [PDF]

Endoscopy
Hou Y, Wei H, Tian J, Hou S, Zhang L.
europepmc   +1 more source